SAkuraBONSAI: A Prospective, Open-label Study of Satralizumab Investigating Novel Imaging, Biomarker, and Clinical Outcomes in Patients with Aquaporin-4-IgG-seropositive (P15.AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD) (P15-1.002)
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available
10.1212/wnl.98.18_supplement.402